Q Global Sponsor for BioAsia 2024: R&D and AI Focus

Trade and Investment Queensland (TIQ), the dedicated business arm of the Queensland Government the global sponsor of Bio Asia 2024, will be held in Hyderabad from 26-28 February.

This event will bring together industry leaders and innovators worldwide to explore the revolutionary journey of RandD, artificial intelligence (AI) and data in the industry and life sciences sectors. With the Queensland team at the forefront of these innovations, the organizer said that Bio Asia 2024 is poised to be a major milestone event in the growing relationship between Queensland and India.

Queensland has a long way to go to make RandD a key economic growth and innovation component. With an ecosystem that fosters collaboration between academia, industry, and government, Queensland is emerging as a RandD leader and seeking partnerships with international partners. Recognizing India's economic growth and R&D environment, Queensland views India as a strategic partner. Participating in BioAsia 2024 is an important step in strengthening Queensland's partnership, demonstrating its commitment to international collaboration and global innovation.

The recent visit of Indian ministers, including Cameron Dick, Deputy Prime Minister, Finance Minister and Trade and Investment Minister, increased cooperation in areas such as technology, R&D, life sciences, biotechnology and AI. Creative direction.Queensland's senior trade and investment adviser for South Asia, Abhinav Bhatia, said: "It's new to the life sciences field."

The Queensland team includes Professor Alan Rowan, Director of the Australian Institute of Biotechnology and Nanotechnology at the University of Queensland (UQ). Tamanna Monem, Director of Development and Partnerships, Queensland Institute of Medical Research (QIMR), Berghofer. Professor Prasad Yarlagadda, Dean of the Faculty of Engineering at the University of Southern Queensland (UniSQ), and Professor Eliza Whiteside, Head of Research at UniSQ, are to promote relationships with Indian companies and institutions.

With representatives from leading Queensland companies such as Microbio, developer of the new molecular diagnostic technology InfectID, Southern RNA, a specialist in the production of nucleic acid products, Aegros, Australia's technology leader in the plasma medicine market, and Clinics, the next generation. Clinical research platforms are at the forefront, demonstrating their work across various life science innovations, from R&D and clinical trials to new data and AI applications. He said that this partnership with India's pharmaceutical industry leaders will pave the way for future dialogue and collaboration, strengthening Queensland and its position as a world leader in this innovative sector.